Skip to main content Back to Top
Advertisement

Congressional Site-Neutral Legislative Proposals Impact on Patients and Providers

Broadcast Date: February 6, 2024

 

Subscribe on iTune PodcastsListen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

Over the last year, Congress has considered proposals to reimburse hospitals and out-patient medical centers at the lower rate of free-standing sites, hoping to reap savings. Unfortunately, these proposals fail to comprehend the significant differences between the pharmacy care and services as well as regulatory framework of care provided in out-patient medical centers in contrast to free-standing sites.

SPEAKERS

Frank KolbFrank Kolb is the federal legislative affairs director at ASHP. He worked in various roles in health care over the last 30 years. His career started as a Legislative Assistant for Illinois Congressman Bobby Rush. He has worked at the Department of Labor and CCIIO. At Delta Dental Plans Association, he was the Director of Policy and Regulatory Relations. He also represented NACo and helped establish the Maryland Health Connection.

Tom KrausTom Kraus, JD, (he/him) is vice president for government relations at ASHP. He is a graduate of University of Michigan (BS Biology), Georgetown University Law Center (Doctor of Law), and The Johns Hopkins University (MHS, Health Policy). Tom previously served as the chief of staff and associate commissioner for legislation at the U.S. Food and Drug Administration. He was also a senior policy advisor to Sen. Ted Kennedy and Sen. Tom Harkin on the Senate Health, Education, Labor and Pensions Committee, where he served as Deputy Staff Director for Health.

Show Notes

Site-Neutral Payments Infographic


The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.